Stake Purchase • Life Science

Motion Equity Partners Invests In Axience Group

On February 21, 2024, private equity firm Motion Equity Partners invested in life science company Axience Group

Investment Context
  • This is Motion Equity Partners’ 4th transaction in the Life Science sector.
  • This is Motion Equity Partners’ 20th transaction in France.

Explore All 282 Stake Purchase Life Science Deals - Search the Database Free


Investment Summary

Date February 21, 2024
Target Axience Group
Sector Life Science
Investor(s) Motion Equity Partners
Deal Type Stake Purchase

Target Company

Axience Group

Pantin, France
Axience Group is a laboratory specialized in development and commercialization of veterinary products. Axience Group develops and commercializes pharmaceutical and OTC products primarily for pets, under its two brands Axience and Anidev. Axience Group was founded in 2001 and is based in Pantin, France.
Explore More Deals

Browse All 215,158 Deals

FILTER BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Search Free

Investor Overview 1

Investor

Motion Equity Partners

Paris, France

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 2001
PE ASSETS 1.0B EUR
Size Large
Type Sector Agnostic
DESCRIPTION

Motion Equity Partners is a European private equity firm that targets large buyouts and turnaround situations valued up to €300 million. Broad areas of interest include consumer (leisure, retail, household and consumer goods, food/beverages), industrial (building materials, automotive, manufacturing, chemicals), business services (outsourced services, logistics and transportation, facilities management), and healthcare services and equipment. Motion prefers opportunities located in France, the UK, Germany, and Italy and looks to commit €20 to €80 per transaction. Motion Equity Partners was established in 2001 and is headquartered in Paris.


Deal Context for Investor #
Overall 44 of 44
Sector: Life Science 4 of 4
Type: Stake Purchase 1 of 1
Country: France 20 of 20
Year: 2024 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2023-11-22 EA Pharma

Vallauris, France

EA Pharma is a pharmaceutical company specialized in production and distribution of drugs, food supplements, and cosmetics. EA Pharma was formed in 2006 and is based in Vallauris, France.

Sell -

Explore Related M&A Activity